slider-1-back

About the Centre

Harnessing world leading science to cure cancer

Find out more about us
bokeh-slider-background

Research

We have achieved a critical mass of investment here in Oxford and the opportunities for cancer research are immense

Find out more...

funding-slider-background

Funding

The Centre supports researchers at every stage of their career and are committed to facilitating more excellent science in Oxford

Learn about our funding

Become part of the Cancer Research UK Oxford Centre Community

Become a Member

Latest news 

An animated drawing of the DNA double helix on a background of DNA sequence (a, c, g, t)

Developing a system to simultaneously detect genetic and epigenetic information

Dr Benjamin Schuster-Böckler wins funding to develop algorithms that can identify both genetic variation and DNA methylation from the same sequencing data, with applications in biomedical research and detection of diseases such as cancer.

Early Detection of Cancer Month

A summary of Early Detection Month in Oxford, February 2021

New Oxford spin-out Singula Bio launches

Singula Bio, co-founded by Professors Ahmed Ahmed, Enzo Cerundolo and Enda McVeigh from the Nuffield Department of Women’s & Reproductive Health, aims to become a world leader in developing neoantigen-based individualised cell therapies to use against difficult-to-treat solid malignancies such as ovarian cancer.

New Oxford technology assesses cancer patient vulnerability to COVID-19

New research from Prof Julia Hippisley-Cox has resulted in thousands of cancer patients being given prioritised access to the COVID-19 vaccine.

Finding extracellular vesicle biomarkers for oesophageal cancer early detection

Prof Deborah Goberdhan’s lab is investigating extracellular vesicles and the proteins they express as potential biomarkers for the progression from Barrett’s Oesophagus to oesophageal cancer

Detecting for multiple cancers in one simple test

Prof. Jason Davis is working alongside clinicians to introduce his biomarker assays into the clinic. Using a range of electroanalytical methods, together with electrode arrays and microfluidics, the platform has the potential to test for many types of cancers all at once, and at an earlier, pre-symptomatic stage.
A molecule of DNA with a radiating light representing mutation

Understanding how inherited and acquired mutations interact to affect cancer

Development fund awardee Gareth Bond is investigating how different types of genetic mutations cooperate to influence cancer risk, progression and response to therapy
Atovaquone molecule

Reprogramming tumour cells using an antimalarial drug

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.

Studying viral genetics to aid liver cancer early detection

Professor Ellie Barnes and Dr Azim Ansari receive funding to identify cancer-associated strains of hepatitis C in Pakistan to improve assessment of liver cancer risk

Twitter

Development fund

Funding

The Centre supports researchers at every stage of their career and are committed to facilitating more excellent science in Oxford.

Learn more
Resources

Research

We have achieved a critical mass of investment here in Oxford and the opportunities for cancer research are immense.

Learn more
DPhil

Graduate studies

Oxford is consistently ranked the world’s best for clinical, pre-clinical, and health training. It is within this rich environment that the Centre implements its strategy for training the next generation of cancer researchers.

Learn more
OCRC symposium

Events

Through our networking and events programme, the Centre brings together the individual components of the Centre into a cohesive community for cancer research.

Learn more

Oxford Centre Films

Participating in an early phase clinical trial (Part 1) – being recruited to a trial

Participating in an early phase clinical trial (Part 2) – during the trial

CRUK Oxford Centre International Symposium on Oesophageal Cancer

Get in touch

Got a Question? Want to learn more about the Centre? Please contact us!

You can also find the centre and get direction using our location page.

Contact us